Quick Answer
DarioHealth Corp. reported R&D Expense of $13.79 million for fiscal year 2025.
DarioHealth Corp. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $13.79M | -43.0% |
| 2024 | $24.18M | +19.4% |
| 2023 | $20.25M | +3.0% |
| 2022 | $19.65M | +14.1% |
| 2021 | $17.22M | +288.4% |
| 2020 | $4.43M | +20.1% |
| 2019 | $3.69M | +0.4% |
| 2018 | $3.68M | +11.5% |
| 2017 | $3.30M | +53.1% |
| 2016 | $2.15M | -16.0% |
| 2015 | $2.56M | -34.9% |
| 2014 | $3.94M | -19.7% |
| 2013 | $4.91M | +227.2% |
| 2012 | $1.50M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.33M | -38.9% | -10.6% |
| June 30, 2025 | $3.72M | -45.4% | -9.4% |
| March 31, 2025 | $4.11M | -38.2% | -24.6% |
| September 30, 2024 | $5.45M | -3.9% | -20.0% |
| June 30, 2024 | $6.81M | +30.4% | +2.5% |
| March 31, 2024 | $6.64M | +28.6% | +17.2% |
| September 30, 2023 | $5.67M | +17.9% | +8.5% |
| June 30, 2023 | $5.22M | +26.2% | +1.1% |
- DarioHealth Corp. showed a decrease of -43.0% in R&D Expense compared to the prior fiscal year.
- Over the 2012–2025 period, DarioHealth Corp.’s r&d expense has grown by 818.6% (from $1.50 million to $13.79 million).
- The most recent figure is from DarioHealth Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: